- Home
- ELAN vs HALO Comparison
ELAN vs HALO Comparison
Compare ELAN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAN
- HALO
- Stock Information
- Founded
- ELAN 1954
- HALO 1998
- Country
- ELAN United States
- HALO United States
- Employees
- ELAN N/A
- HALO N/A
- Industry
- ELAN Biotechnology: Pharmaceutical Preparations
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELAN Health Care
- HALO Health Care
- Exchange
- ELAN Nasdaq
- HALO Nasdaq
- Market Cap
- ELAN 7.2B
- HALO 7.4B
- IPO Year
- ELAN 2018
- HALO N/A
- Fundamental
- Price
- ELAN $13.99
- HALO $62.32
- Analyst Decision
- ELAN Buy
- HALO Buy
- Analyst Count
- ELAN 7
- HALO 9
- Target Price
- ELAN $16.17
- HALO $68.78
- AVG Volume (30 Days)
- ELAN 4.5M
- HALO 1.5M
- Earning Date
- ELAN 08-07-2025
- HALO 08-05-2025
- Dividend Yield
- ELAN N/A
- HALO N/A
- EPS Growth
- ELAN N/A
- HALO 68.90
- EPS
- ELAN 0.75
- HALO 4.37
- Revenue
- ELAN $4,427,000,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- ELAN $4.44
- HALO $25.38
- Revenue Next Year
- ELAN $4.79
- HALO $20.19
- P/E Ratio
- ELAN $18.59
- HALO $14.28
- Revenue Growth
- ELAN 1.42
- HALO 34.97
- 52 Week Low
- ELAN $8.02
- HALO $42.01
- 52 Week High
- ELAN $15.78
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- ELAN 44.95
- HALO 69.70
- Support Level
- ELAN $13.39
- HALO $58.53
- Resistance Level
- ELAN $14.40
- HALO $61.75
- Average True Range (ATR)
- ELAN 0.40
- HALO 1.58
- MACD
- ELAN -0.13
- HALO 0.30
- Stochastic Oscillator
- ELAN 33.52
- HALO 68.44
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.